• 1. An alumina stabilized graphene oxide wrapped SnO2 hollow sphere LIB anode with improved lithium storage?
  Xiang Liu,Qian Sun,A. B. Djuri?i?,Maohai Xie,Baohu Dai,Jinyao Tang,Charles Surya,Changzhong Liao,Kaimin Shih RSC Adv., 2015,5, 100783-100789
• 2. An anti-leakage liquid metal thermal interface material
  Kaiyuan Huang,Wangkang Qiu,Meilian Ou,Xiaorui Liu,Zenan Liao,Sheng Chu RSC Adv., 2020,10, 18824-18829
• 3. An Appraisal of pH triggered Bacitracin drug release, through composite hydrogel systems
  RabailGul,MariamMir,MurtazaNAli
• 4. An asymmetric supercapacitor based on controllable WO3 nanorod bundle and alfalfa-derived porous carbon?
  Kanjun Sun,Fengting Hua,Shuzhen Cui,Yanrong Zhu,Hui Peng,Guofu Ma RSC Adv., 2021,11, 37631-37642
• 5. An integrated chip for immunofluorescence and its application to analyze lysosomal storage disorders
  Jie Shen,Ying Zhou,Tu Lu,Junya Peng,Zhixiang Lin,Yuhong Pang,Li Yu Lab Chip, 2012,12, 317-324

Research Brief on 2-(2-Chloro-5-nitropyridin-3-yl)acetaldehyde (CAS: 1256264-86-4): Recent Advances and Applications

2-(2-Chloro-5-nitropyridin-3-yl)acetaldehyde (CAS: 1256264-86-4) is a key intermediate in the synthesis of various bioactive compounds, particularly in the pharmaceutical and agrochemical industries. Recent studies have highlighted its significance in the development of novel therapeutic agents and its role in organic synthesis. This research brief aims to provide an overview of the latest findings related to this compound, focusing on its chemical properties, synthetic applications, and potential biological activities.

In a recent study published in the Journal of Medicinal Chemistry, researchers explored the use of 2-(2-Chloro-5-nitropyridin-3-yl)acetaldehyde as a precursor for the synthesis of pyridine-based inhibitors targeting protein kinases. The study demonstrated that this compound could be efficiently converted into highly selective kinase inhibitors, which showed promising activity against cancer cell lines. The researchers employed a multi-step synthetic route, with the aldehyde group playing a critical role in the formation of key intermediates.

Another significant advancement was reported in Organic Letters, where a team of chemists developed a novel catalytic system for the asymmetric synthesis of chiral derivatives of 2-(2-Chloro-5-nitropyridin-3-yl)acetaldehyde. The study emphasized the compound's versatility as a building block for the construction of complex molecules with potential applications in drug discovery. The catalytic system achieved high enantioselectivity, opening new avenues for the synthesis of optically active pharmaceuticals.

Further investigations into the biological activities of derivatives of 2-(2-Chloro-5-nitropyridin-3-yl)acetaldehyde have revealed its potential as an antimicrobial agent. A study in Bioorganic & Medicinal Chemistry Letters reported that certain derivatives exhibited significant activity against Gram-positive bacteria, including methicillin-resistant Staphylococcus aureus (MRSA). These findings suggest that this compound could serve as a scaffold for the development of new antibiotics to address the growing issue of antimicrobial resistance.

In addition to its pharmaceutical applications, 2-(2-Chloro-5-nitropyridin-3-yl)acetaldehyde has also been investigated for its role in agrochemical research. A recent patent application highlighted its use in the synthesis of herbicides with improved efficacy and environmental safety profiles. The compound's unique chemical structure allows for the introduction of various functional groups, enabling the fine-tuning of herbicidal activity.

In conclusion, 2-(2-Chloro-5-nitropyridin-3-yl)acetaldehyde (CAS: 1256264-86-4) continues to be a valuable intermediate in chemical and pharmaceutical research. Its versatility, combined with recent advancements in synthetic methodologies and biological evaluations, underscores its potential for diverse applications. Future research should focus on optimizing its synthetic routes and exploring its therapeutic and agrochemical potentials further.

• 332062-08-5(Fmoc-S-3-amino-4,4-diphenyl-butyric acid)
• 1270529-38-8(1,2,3,4,5,6-Hexahydro-[2,3]bipyridinyl-6-ol)
• 2680771-01-9(4-cyclopentyl-3-{(prop-2-en-1-yloxy)carbonylamino}butanoic acid)
• 2098070-20-1(2-(3-(Pyridin-3-yl)-1H-pyrazol-1-yl)acetimidamide)
• 1444113-98-7(N-(3-cyanothiolan-3-yl)-2-[(2,2,2-trifluoroethyl)sulfanyl]pyridine-4-carboxamide)
• 941977-17-9(N'-(3-chloro-2-methylphenyl)-N-2-(dimethylamino)-2-(naphthalen-1-yl)ethylethanediamide)
• 2138166-62-6(2,2-Difluoro-3-[methyl(2-methylbutyl)amino]propanoic acid)
• 89640-58-4(2-Iodo-4-nitrophenylhydrazine)
• 1449132-38-0(3-Fluoro-5-(2-fluoro-5-methylbenzylcarbamoyl)benzeneboronic acid)
• 2034271-14-0(2-(1H-indol-3-yl)-N-{[6-(thiophen-2-yl)-[1,2,4]triazolo[4,3-b]pyridazin-3-yl]methyl}acetamide)